Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

Cited In for PubMed (Select 18511303)

1.

Serotonin and mental disorders: a concise review on molecular neuroimaging evidence.

Lin SH, Lee LT, Yang YK.

Clin Psychopharmacol Neurosci. 2014 Dec;12(3):196-202. doi: 10.9758/cpn.2014.12.3.196. Epub 2014 Dec 26. Review.

2.

Body Dysmorphic Disorder: Neurobiological Features and an Updated Model.

Li W, Arienzo D, Feusner JD.

Z Klin Psychol Psychother (Gott). 2013;42(3):184-191.

3.

PET tracers for serotonin receptors and their applications.

Kumar JS, Mann JJ.

Cent Nerv Syst Agents Med Chem. 2014;14(2):96-112.

4.

Compulsivity in anorexia nervosa: a transdiagnostic concept.

Godier LR, Park RJ.

Front Psychol. 2014 Jul 17;5:778. doi: 10.3389/fpsyg.2014.00778. eCollection 2014. Review.

5.

Response inhibition and interference control in obsessive-compulsive spectrum disorders.

van Velzen LS, Vriend C, de Wit SJ, van den Heuvel OA.

Front Hum Neurosci. 2014 Jun 11;8:419. doi: 10.3389/fnhum.2014.00419. eCollection 2014. Review.

6.

Behavioral and neural effects of intra-striatal infusion of anti-streptococcal antibodies in rats.

Lotan D, Benhar I, Alvarez K, Mascaro-Blanco A, Brimberg L, Frenkel D, Cunningham MW, Joel D.

Brain Behav Immun. 2014 May;38:249-62. doi: 10.1016/j.bbi.2014.02.009. Epub 2014 Feb 20.

7.

Dopaminergic control of cognitive flexibility in humans and animals.

Klanker M, Feenstra M, Denys D.

Front Neurosci. 2013 Nov 5;7:201. doi: 10.3389/fnins.2013.00201. Review.

8.

Nucleus accumbens high-frequency stimulation selectively impacts nigrostriatal dopaminergic neurons.

Sesia T, Bizup B, Grace AA.

Int J Neuropsychopharmacol. 2014 Mar;17(3):421-7. doi: 10.1017/S1461145713001211. Epub 2013 Oct 17.

9.

Role of the 5-HT₂A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice.

Halberstadt AL, Powell SB, Geyer MA.

Neuropharmacology. 2013 Jul;70:218-27. doi: 10.1016/j.neuropharm.2013.01.014. Epub 2013 Jan 29.

10.

Evaluation of animal models of obsessive-compulsive disorder: correlation with phasic dopamine neuron activity.

Sesia T, Bizup B, Grace AA.

Int J Neuropsychopharmacol. 2013 Jul;16(6):1295-307. doi: 10.1017/S146114571200154X. Epub 2013 Jan 29.

11.

In vivo imaging of dopaminergic neurotransmission after transient focal ischemia in rats.

Martín A, Gómez-Vallejo V, San Sebastián E, Padró D, Markuerkiaga I, Llarena I, Llop J.

J Cereb Blood Flow Metab. 2013 Feb;33(2):244-52. doi: 10.1038/jcbfm.2012.162. Epub 2012 Nov 14.

12.

Frontostriatal cognitive staging in Parkinson's disease.

de la Fuente-Fernández R.

Parkinsons Dis. 2012;2012:561046. doi: 10.1155/2012/561046. Epub 2011 Dec 6.

13.

Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment.

Pittenger C, Bloch MH, Williams K.

Pharmacol Ther. 2011 Dec;132(3):314-32. doi: 10.1016/j.pharmthera.2011.09.006. Epub 2011 Sep 22. Review.

14.

Serotonin 2A receptors in obsessive-compulsive disorder: a positron emission tomography study with [11C]MDL 100907.

Simpson HB, Slifstein M, Bender J Jr, Xu X, Hackett E, Maher MJ, Abi-Dargham A.

Biol Psychiatry. 2011 Nov 1;70(9):897-904. doi: 10.1016/j.biopsych.2011.06.023.

15.

Extended characterisation of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in humans: quantitative analysis, test-retest reproducibility, and vulnerability to endogenous 5-HT tone.

Talbot PS, Slifstein M, Hwang DR, Huang Y, Scher E, Abi-Dargham A, Laruelle M.

Neuroimage. 2012 Jan 2;59(1):271-85. doi: 10.1016/j.neuroimage.2011.07.001. Epub 2011 Jul 18.

16.

5-HT radioligands for human brain imaging with PET and SPECT.

Paterson LM, Kornum BR, Nutt DJ, Pike VW, Knudsen GM.

Med Res Rev. 2013 Jan;33(1):54-111. doi: 10.1002/med.20245. Epub 2011 Jun 14. Review.

17.

Brain regional α-[11C]methyl-L-tryptophan trapping in medication-free patients with obsessive-compulsive disorder.

Berney A, Leyton M, Gravel P, Sibon I, Sookman D, Rosa Neto P, Diksic M, Nakai A, Pinard G, Todorov C, Okazawa H, Blier P, Nordahl TE, Benkelfat C.

Arch Gen Psychiatry. 2011 Jul;68(7):732-41. doi: 10.1001/archgenpsychiatry.2011.16. Epub 2011 Mar 7.

18.

Influence of compulsivity of drug abuse on dopaminergic modulation of attentional bias in stimulant dependence.

Ersche KD, Bullmore ET, Craig KJ, Shabbir SS, Abbott S, Müller U, Ooi C, Suckling J, Barnes A, Sahakian BJ, Merlo-Pich EV, Robbins TW.

Arch Gen Psychiatry. 2010 Jun;67(6):632-44. doi: 10.1001/archgenpsychiatry.2010.60.

19.

Social deficits, stereotypy and early emergence of repetitive behavior in the C58/J inbred mouse strain.

Ryan BC, Young NB, Crawley JN, Bodfish JW, Moy SS.

Behav Brain Res. 2010 Mar 17;208(1):178-88. doi: 10.1016/j.bbr.2009.11.031. Epub 2009 Nov 24.

20.

Invasive circuitry-based neurotherapeutics: stereotactic ablation and deep brain stimulation for OCD.

Greenberg BD, Rauch SL, Haber SN.

Neuropsychopharmacology. 2010 Jan;35(1):317-36. doi: 10.1038/npp.2009.128. Epub . Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk